comparemela.com
Home
Live Updates
Biotech Stocks Facing FDA Decision In February 2024 : comparemela.com
Biotech Stocks Facing FDA Decision In February 2024
The year 2024 has begun on a muted note in terms of FDA approvals, with only one novel drug getting endorsed in January. Let's take a look at the biotech companies that are awaiting FDA word on their drug candidates in February.
Related Keywords
Canada
,
United States
,
Abbvie Humira
,
Minerva Neurosciences Inc
,
Iovance Biotherapeutics Inc
,
Minerva Neuroscience New Drug Application
,
Cancer
,
Pdufa
,
Eda Decision
,
Soil
,
Lifileucel
,
Scizophrenia
,
comparemela.com © 2020. All Rights Reserved.